Endo International plc Contracts & Agreements

260 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Purchase and Sale Agreement among Endo Enterprise, Inc., Endo USA, Inc., Paladin Pharma Inc., and Endo International plc (April 14, 2024)
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2024
Settlement Agreement Among United States Government Entities and Endo International plc Regarding Bankruptcy and Opana ER Investigations
Settlement Agreements
Endo International plc
Pharmaceuticals
2024
Plea Agreement Between U.S. Department of Justice and Endo Health Solutions Inc. Regarding Opana ER Misbranding
Settlement Agreements
Endo International plc
Pharmaceuticals
2024
Settlement Agreement Among United States, Endo Health Solutions Inc., and Relator Loretta Reed
Settlement Agreements
Endo International plc
Pharmaceuticals
FL
2024
Endo International plc 2022 Retention Bonus Agreement with Blaise Coleman
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International 2022 Retention Bonus Agreement with Mark Bradley
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc 2022 Retention Bonus Letter Agreement with Matthew Maletta
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc 2022 Retention Bonus Agreement with Patrick Barry
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2022
Amendment to Employment Agreement between Endo International plc and Blaise Coleman
Employment Agreements
Endo International plc
Pharmaceuticals
2022
Amendment to Employment Agreement Between Endo International plc and Patrick Barry (August 13, 2022)
Employment Agreements
Endo International plc
Pharmaceuticals
2022
Amendment to Employment Agreement between Endo International plc and Mark Bradley
Employment Agreements
Endo International plc
Pharmaceuticals
2022
Amendment to Employment Agreement between Endo International plc and Matthew Maletta (August 2022)
Employment Agreements
Endo International plc
Pharmaceuticals
2022
Description of Endo International plc Ordinary Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Endo International plc
Pharmaceuticals
2022
Endo International plc 2021 Retention Bonus Agreement with Blaise Coleman
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc 2021 Retention Bonus Agreement with Mark Bradley
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc 2021 Retention Bonus Agreement with Matthew
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc 2021 Retention Bonus Agreement with Patrick Barry
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2022
Endo International plc Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan
Equity Distribution Agreements
Endo International plc
Pharmaceuticals
DE
2021
Endo International plc Performance Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2021
Endo International plc Long-Term Cash Award Agreement Under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2021
Endo Continuity Compensation Agreement with George Apostol (November 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
2021
Executive Employment Agreement between Endo Ventures Limited and George Apostol, MD, MS (April 29, 2021)
Employment Agreements
Endo International plc
Pharmaceuticals
2021
Indenture for 6.125% Senior Secured Notes due 2029 among Endo Luxembourg Finance Company I S.à r.l., Endo U.S. Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2021
Description of Endo International plc Ordinary Shares Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Endo International plc
Pharmaceuticals
2021
Separation Agreement and General Release between Terrance J. Coughlin and Endo Health Solutions, Inc.
Separation Agreements
Endo International plc
Pharmaceuticals
DE
2021
Endo Continuity Compensation Agreement with Blaise Coleman (November 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
2021
Endo Continuity Compensation Agreement with Patrick Barry (November 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
2021
Endo Continuity Compensation Agreement with Mark Bradley (November 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
2021
Endo Continuity Compensation Agreement with Matthew Maletta (November 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
2021
Executive Employment Agreement between Endo Health Solutions Inc. and Matthew J. Maletta
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2020
Agreement and Plan of Merger among Endo International plc, Beta Acquisition Corp., and BioSpecifics Technologies Corp. dated October 19, 2020
Merger Agreements
Endo International plc
Pharmaceuticals
DE
2020
Support Agreement among Endo International plc, Beta Acquisition Corp., and the Marital Trust U/W/O Edwin H. Wegman
Voting Agreements
Endo International plc
Pharmaceuticals
DE
2020
First Supplemental Indenture to 7.500% Senior Secured Notes Due 2027 – Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2020
Indenture for 9.500% Senior Secured Second Lien Notes due 2027 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
Indenture for 6.000% Senior Notes due 2028 among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2020
Supplemental Indenture to 6.000% Senior Notes Due 2023 Among Endo DAC, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Supplemental Indenture to 6.000% Senior Notes Due 2025 Among Endo Designated Activity Company, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2020
Collateral Trust Agreement among Endo International PLC, Affiliates, and Wilmington Trust, Dated April 27, 2017
Trust Agreements
Endo International plc
Pharmaceuticals
NY
2020
Second Lien Collateral Trust Agreement among Endo International PLC, Affiliates, Wells Fargo Bank, and Wilmington Trust (June 16, 2020)
Trust Agreements
Endo International plc
Pharmaceuticals
DE
2020
Intercreditor Agreement among Wilmington Trust, Endo International PLC, and Grantors (June 16, 2020)
Trust Agreements
Endo International plc
Pharmaceuticals
NY
2020
Endo International plc Amended and Restated 2015 Stock Incentive Plan (as of June 11, 2020)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2020
Endo International plc Performance Award Agreement under the 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2020
Endo International plc Long-Term Cash Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2020
Executive Employment Agreement between Endo Health Solutions Inc. and Patrick Barry
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2020
Endo and Patrick Barry Contribution Retention Bonus Agreement (August 2019)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
PA
2020
Description of Endo International plc Ordinary Shares Registered Under Section 12 of the Exchange Act
Stock Agreements
Endo International plc
Pharmaceuticals
2020
Executive Employment Agreement between Endo Health Solutions Inc. and Blaise Coleman (CEO)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2020
Executive Employment Agreement between Endo Health Solutions Inc. and Mark Bradley (CFO)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2020
Endo Contribution Retention Bonus Agreement with Mark Bradley (August 2019)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
PA
2020
Endo/Mark Bradley Retention Bonus and Severance Letter Agreement (May 17, 2018)
Retention Agreements
Endo International plc
Pharmaceuticals
2020
Executive Employment Agreement between Endo Health Solutions Inc. and Blaise Coleman
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2019
Executive Employment Agreement between Endo Health Solutions Inc. and Terrance J. Coughlin (2019)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2019
Succession Planning and Transition Letter Agreement between Endo International plc and Paul V. Campanelli
Compensation Agreements
Endo International plc
Pharmaceuticals
NY
2019
Supplemental Indenture to 7.25% Senior Notes Due 2022 between Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2019
Endo International plc and Blaise Coleman Contribution Retention Bonus Agreement (August 2019)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
PA
2019
Endo Contribution Retention Bonus Agreement with Terrance Coughlin (August 2019)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
CA
2019
Endo International plc and Matthew Maletta Contribution Retention Bonus Agreement
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
PA
2019
Endo International plc Amended and Restated 2015 Stock Incentive Plan (as of June 11, 2019)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2019
Second Amendment to Second Amended and Restated Development and License Agreement between BioSpecifics Technologies Corp. and Endo Global Ventures
License Agreements
Endo International plc
Pharmaceuticals
NY
2019
Endo International plc Performance Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2019
Executive Employment Agreement between Endo Health Solutions Inc. and Paul Campanelli (April 24, 2019)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2019
Retirement Considerations Agreement and General Release between Antonio Pera and Endo Health Solutions Inc.
Retirement Agreements
Endo International plc
Pharmaceuticals
PA
2019
First Amendment to Credit Agreement among Endo International PLC, Endo Luxembourg Finance Company I S.r.l., Endo LLC, JPMorgan Chase Bank, N.A., and Lenders (March 28, 2019)
Credit Agreements
Endo International plc
Pharmaceuticals
NY
2019
Indenture for 7.500% Senior Secured Notes due 2027 among Par Pharmaceutical, Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2019
Executive Employment Agreement between Endo Health Solutions Inc. and Antonio Pera
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2019
Endo International plc Stock Option Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Stock Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Performance Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Stock Option Agreement under the Amended and Restated 2015 Stock Incentive Plan
Warrant Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Stock Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Performance Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Long-Term Cash Incentive Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo Health Solutions Inc. Amended and Restated Executive Deferred Compensation Plan (Effective July 31, 2018)
Compensation Agreements
Endo International plc
Pharmaceuticals
2018
Endo International plc Amended and Restated 2015 Stock Incentive Plan (as of June 7, 2018)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Endo International plc Performance Stock Unit Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2018
Membership Interest and Asset Purchase Agreement between Mendham Holdings, LLC, Endo Ventures Limited, Par Pharmaceutical, Inc., and Seller Related Parties (April 26, 2018)
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2018
Executive Employment Agreement between Endo Health Solutions Inc. and Matthew J. Maletta (2018)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2018
Fifth Amendment to Supply and Manufacturing Agreement between Teikoku and Endo
Supply Agreements
Endo International plc
Pharmaceuticals
2017
Purchase Agreement among Endo Somar Holdings B.V., Affiliates, and AI Global Investments (Netherlands) PCC Limited (Soar Cell) – Grupo Farmacéutico Somar, S.A.P.I. de C.V. Sale
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2017
Endo International plc Amended and Restated 2015 Stock Incentive Plan (as Amended June 8, 2017)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2017
Sale Agreement Between Endo Luxembourg Finance Companies, Endo Ventures Limited, and Acino Pharma AG
Purchase Agreements
Endo International plc
Pharmaceuticals
2017
Purchase Agreement for $300,000,000 5.875% Senior Secured Notes due 2024 by Endo DAC, Endo Finance LLC, and Endo Finco Inc. with Initial Purchasers
Purchase Agreements
Endo International plc
Pharmaceuticals
NY
2017
Endo International plc Non-Qualified Stock Option Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2017
Endo International plc Stock Award Agreement under the Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2017
Endo International plc Performance Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2017
Endo International plc Long-Term Cash Incentive Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2017
Amendment No. 2 to Credit Agreement among Endo Luxembourg Finance Company I S.à r.l., Endo LLC, and Deutsche Bank AG New York Branch
Credit Agreements
Endo International plc
Pharmaceuticals
NY
2017
Executive Employment Agreement between Endo Health Solutions Inc. and Blaise Coleman
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2016
Separation Agreement and General Release between Susan Hall and Endo Health Solutions Inc.
Separation Agreements
Endo International plc
Pharmaceuticals
DE
2016
Executive Employment Agreement between Endo Health Solutions Inc. and Terrance J. Coughlin
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2016
Executive Employment Agreement between Endo Health Solutions Inc. and Paul Campanelli (2016)
Employment Agreements
Endo International plc
Pharmaceuticals
PA
2016
Separation Agreement between Endo Health Solutions Inc. and Rajiv De Silva
Separation Agreements
Endo International plc
Pharmaceuticals
DE
2016
Master Supply Agreement between Jubilant HollisterStier LLC and Endo Ventures Limited
Supply Agreements
Endo International plc
Pharmaceuticals
NY
2016
Endo International plc Amended and Restated 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2016
Executive Employment Agreement between Endo Health Solutions Inc. and Suketu P. Upadhyay
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2016
Endo Ventures Limited Notice of Non-Renewal and Termination of Supply Agreement with Noramco, Inc.
Termination Agreements
Endo International plc
Pharmaceuticals
2016
Third Amendment to Supply Agreement between Endo Pharmaceuticals Inc. and Noramco, Inc.
Supply Agreements
Endo International plc
Pharmaceuticals
2016
Fourth Amendment to Supply Agreement between Endo Ventures Limited and Noramco, Inc.
Supply Agreements
Endo International plc
Pharmaceuticals
2016
Fifth Amendment to Supply Agreement between Endo Ventures Limited and Noramco, Inc.
Supply Agreements
Endo International plc
Pharmaceuticals
2016
Endo International plc Stock Option Agreement under 2015 Stock Incentive Plan
Warrant Agreements
Endo International plc
Pharmaceuticals
DE
2016
Endo International plc Stock Award Agreement under 2015 Stock Incentive Plan
Stock Agreements
Endo International plc
Pharmaceuticals
DE
2016
Endo International plc Performance Award Agreement under 2015 Stock Incentive Plan
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2016
Letter Agreement Amending License and Supply Agreement for Voltaren® Gel Authorized Generic between Sandoz, Novartis AG, and Endo Ventures Limited
Modification Agreements
Endo International plc
Pharmaceuticals
2016
Indemnification Agreement between Endo International plc and Director/Officer (2016)
Indemnification Agreements
Endo International plc
Pharmaceuticals
2016
Amendment to Shareholders Agreement and Registration Rights Agreement among TPG Sky L.P., TPG Sky Co-Invest L.P., TPG Biotechnology Partners IV L.P., and Endo International plc
Modification Agreements
Endo International plc
Pharmaceuticals
2016
Director Confidentiality Agreement between Endo International plc, Todd B. Sisitsky, and TPG Global, LLC
Confidentiality Agreements
Endo International plc
Pharmaceuticals
2016
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2016
Supplemental Indenture to 7.25% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Endo Limited, Affiliates, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2016
Amended and Restated License and Supply Agreement among Novartis AG, Sandoz Inc., and Endo Ventures Limited (2015)
License Agreements
Endo International plc
Pharmaceuticals
DE
2016
Indemnification Agreement between Endo Health Solutions Inc. and Director/Officer
Indemnification Agreements
Endo International plc
Pharmaceuticals
DE
2016
Executive Employment Agreement between Endo Health Solutions Inc. and Rajiv De Silva (2016)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2016
First Amendment to Second Amended and Restated Development and License Agreement between BioSpecifics Technologies Corp. and Endo Global Ventures
License Agreements
Endo International plc
Pharmaceuticals
NY
2016
Termination Notice of License and Commercial Supply Agreements between Auxilium Pharmaceuticals, Endo Ventures, and Vivus
Termination Agreements
Endo International plc
Pharmaceuticals
2015
License and Supply Agreement between Novartis AG, Novartis Consumer Health, Inc., and Endo Pharmaceuticals Inc.
License Agreements
Endo International plc
Pharmaceuticals
NJ
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Par Pharmaceutical Subsidiaries, Endo Designated Activity Company, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 (Endo Finance LLC and Subsidiaries)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 Among Endo Finance Entities, Par Pharmaceutical Subsidiaries, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Par Pharmaceutical Companies, Inc., Subsidiaries, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 – Guarantor Joinder (Endo Finance LLC et al.)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 Among Endo Finance Entities, Subsidiaries, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.000% Senior Notes Due 2023 among Par Pharmaceutical Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Executive Employment Agreement between Endo Health Solutions Inc. and Paul Campanelli (2015)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2015
First Amendment to License and Supply Agreement between Novartis and Endo Pharmaceuticals
License Agreements
Endo International plc
Pharmaceuticals
2015
Second Amendment to License and Supply Agreement between Endo Pharmaceuticals Inc., Novartis Consumer Health, Inc., and Novartis AG
License Agreements
Endo International plc
Pharmaceuticals
2015
Incremental Amendment to Credit Agreement among Endo Luxembourg Finance Company I S.A R.L. and Lenders (September 25, 2015)
Credit Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc 2015 Stock Option Agreement with Participant under Stock Incentive Plan
Warrant Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc 2015 Stock Incentive Plan Restricted Stock Unit Award Agreement
Stock Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc 2015 Stock Incentive Plan Performance Share Unit Award Agreement
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc 2015 Stock Incentive Plan Matched Performance Award Agreement
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2019 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 – Endo Limited and Subsidiaries, Wells Fargo Bank, N.A. as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 – Endo Finance LLC and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023—Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 – Endo Finance LLC and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 Among Endo Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 – Endo Finance LLC and Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2019 – Endo Finance LLC, Endo Finco Inc., and Ishirini Limited
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 (Endo Finance LLC, Endo Finco Inc., and Ishirini Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 (Endo Finance LLC, Endo Finco Inc., and Ishirini Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.375% Senior Notes Due 2023 among Endo Finance Entities, Guarantors, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 (Endo Finance LLC, Endo Finco Inc., and Ishirini Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 – Endo Finance Entities and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Second Amendment to Master Services Agreement between UPS Supply Chain Solutions, Inc. and Endo Pharmaceuticals Inc.
Modification Agreements
Endo International plc
Pharmaceuticals
2015
Indenture for 6.000% Senior Notes Due 2023 among Endo Limited, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc Ordinary Shares Underwriting Agreement with Goldman Sachs, J.P. Morgan, Barclays, and Deutsche Bank (June 2015)
Underwriting Agreements
Endo International plc
Pharmaceuticals
NY
2015
Agreement and Plan of Merger among Endo International plc, Par Pharmaceutical Holdings, Inc., and Related Parties (May 18, 2015)
Merger Agreements
Endo International plc
Pharmaceuticals
NY
2015
Registration Rights Agreement between Endo International plc and Certain Shareholders (May 18, 2015)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
DE
2015
Shareholders Agreement dated May 18, 2015 by and among Endo International plc and Certain Shareholders
Shareholders Agreements
Endo International plc
Pharmaceuticals
CO
2015
Commitment Letter for Senior Secured Credit Facilities and Bridge Facilities – Endo Limited, Barclays Bank PLC, and Deutsche Bank AG New York Branch
Endo International plc
Pharmaceuticals
NY
2015
Purchase Agreement among American Medical Systems Holdings, Inc., Endo Health Solutions Inc., and Boston Scientific Corporation dated March 2, 2015
Purchase Agreements
Endo International plc
Pharmaceuticals
DE
2015
Supplemental Indenture to 7.00% Senior Notes Due 2019 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2019 (Endo Finance LLC, Endo Finco Inc., Aphrodite Women’s Health, LLC, Endo Ventures Cyprus Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 (Endo Finance LLC, Endo Finco Inc., Aphrodite Women’s Health, LLC, Endo Ventures Cyprus Limited)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.25% Senior Notes Due 2022 Among Endo Entities and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 – Endo Finance LLC and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.75% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Aphrodite Women’s Health, LLC, Endo Ventures Cyprus Limited, and Wells Fargo...
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 Among Endo Entities and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 – Endo Finance LLC, Endo Finco Inc., and Guarantors
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 6.00% Senior Notes Due 2025 Among Endo Limited, Subsidiaries, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes due 2025 (Aphrodite Women’s Health, LLC, Endo Ventures Cyprus Limited, and Others)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Executive Employment Agreement between Endo Health Solutions Inc. and Matthew J. Maletta (April 28, 2015)
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2015
Fourth Amendment to Supply and Manufacturing Agreement between Teikoku Seiyaku Co., Ltd./Teikoku Pharma USA, Inc. and Endo Pharmaceuticals Inc.
Supply Agreements
Endo International plc
Pharmaceuticals
2015
Retention and Consulting Agreement between Endo Health Solutions Inc. and Caroline B. Manogue
Retention Agreements
Endo International plc
Pharmaceuticals
DE
2015
Executive Employment Agreement between American Medical Systems, Inc. and Camille Farhat
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2015
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Endo Limited Subsidiaries, Issuers, Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 (Endo Finance LLC, Endo Finco Inc., Guarantors, Citigroup Global Markets Inc., RBC Capital Markets)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7% Senior Notes Due 2019 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2019 (Endo Finance LLC, Endo Finco Inc., Guarantors, RBC Capital Markets, LLC, Deutsche Bank Securities...
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Endo Limited Subsidiaries, Issuers, Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes Due 2020 (Endo Finance LLC, Endo Finco Inc., and Guarantors)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.25% Senior Notes Due 2022 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 (Endo Finance LLC, Endo Finco Inc., and Guarantors)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 5.375% Senior Notes Due 2023 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 among Endo Finance LLC, Endo Finco Inc., and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 7.00% Senior Notes Due 2019 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2019 by Endo Finance LLC and Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.00% Senior Notes Due 2020 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.00% Senior Notes due 2020 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture to 7.25% Senior Notes Due 2022 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 7.25% Senior Notes due 2022 (Endo Finance LLC and Subsidiaries)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture for 6.00% Senior Notes Due 2025 Among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Counterpart to Registration Rights Agreement for 6.00% Senior Notes Due 2025 – Endo Finance LLC and Guaranteeing Subsidiaries
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2015
Supplemental Indenture and Guarantee Agreement for 5.75% Senior Notes due 2022 among Endo Limited Subsidiaries and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2015
Separation Agreement between Endo Health Solutions Inc. and Donald DeGolyer
Separation Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc Performance Award Agreement under 2010 Stock Incentive Plan (Off-Cycle Grant)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc Performance Award Agreement under 2010 Stock Incentive Plan (2015)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc Performance Stock Unit Award Agreement (Off-Cycle, Assumed Plan)
Bonus & Incentive Agreements
Endo International plc
Pharmaceuticals
DE
2015
Endo International plc Performance Stock Unit Award Agreement (2015)
Compensation Agreements
Endo International plc
Pharmaceuticals
DE
2015
Retention Bonus Agreement between Endo International plc and Camille Farhat (American Medical Systems, Inc.)
Retention Agreements
Endo International plc
Pharmaceuticals
2015
Second Supplemental Indenture to 1.50% Convertible Senior Notes due 2018 among Auxilium Pharmaceuticals, Endo International, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2015
Second Supplemental Indenture to 1.50% Convertible Senior Notes due 2018 among Auxilium Pharmaceuticals, Endo International, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
NY
2015
Indenture for 6.00% Senior Notes Due 2025 among Endo Limited, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2015
Registration Rights Agreement among Endo Limited, Endo Finance LLC, Endo Finco Inc., and Initial Purchasers
Registration Rights Agreements
Endo International plc
Pharmaceuticals
NY
2015
Loan Agreement among Auxilium Pharmaceuticals, Inc., Auxilium UK LTD, and Endo Pharmaceuticals Inc. dated November 17, 2014
Loan Agreements
Endo International plc
Pharmaceuticals
DE
2014
Supplemental Indenture to 7.00% Senior Notes Due 2019—DAVA Pharmaceuticals Guarantee
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 7.00% Senior Notes Due 2019
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture and Guarantee Agreement for 7.00% Senior Notes due 2020 among DAVA Pharmaceuticals, Endo Entities, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 7.00% Senior Notes Due 2020 (DAVA Guarantee)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.25% Senior Notes Due 2022—DAVA Pharmaceuticals, Endo Entities, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 7.25% Senior Notes Due 2022
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 5.75% Senior Notes Due 2022—DAVA Pharmaceuticals, Endo Finance LLC, Endo Finco Inc., and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 5.375% Senior Notes Due 2023—DAVA Pharmaceuticals, Endo Entities, and Wells Fargo as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
DAVA Pharmaceuticals Counterpart to Registration Rights Agreement for 5.375% Senior Notes Due 2023
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Amended and Restated Commitment Letter for Incremental Term Loan B Credit Facility – Endo Limited and Initial Lenders
Endo International plc
Pharmaceuticals
NY
2014
Agreement and Plan of Merger among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc.
Merger Agreements
Endo International plc
Pharmaceuticals
DE
2014
Partial Unwind Agreement between Endo Health Solutions Inc. and Deutsche Bank AG, London Branch (April 17, 2014)
Modification Agreements
Endo International plc
Pharmaceuticals
NY
2014
Partial Unwind Agreement between Endo Health Solutions Inc. and Deutsche Bank AG, London Branch (April 21, 2014)
Modification Agreements
Endo International plc
Pharmaceuticals
NY
2014
Partial Unwind Agreement between Endo Health Solutions Inc. and Deutsche Bank AG, London Branch (April 22, 2014)
Modification Agreements
Endo International plc
Pharmaceuticals
NY
2014
Partial Unwind Agreement between Endo Health Solutions Inc. and Deutsche Bank AG, London Branch (July 21, 2014)
Modification Agreements
Endo International plc
Pharmaceuticals
NY
2014
Partial Unwind Agreement between Endo Health Solutions Inc. and Deutsche Bank AG, London Branch (July 21, 2014)
Modification Agreements
Endo International plc
Pharmaceuticals
NY
2014
Endo International plc Amended and Restated Employee Stock Purchase Plan
Stock Agreements
Endo International plc
Pharmaceuticals
DE
2014
Supplemental Indenture to 5.75% Senior Notes Due 2022—Endo Ventures Bermuda Limited, Endo Finance LLC, Endo Finco Inc., Wells Fargo Bank, N.A., and Guarantors
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Ventures Bermuda Limited (May 28, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Ventures Bermuda Limited, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Ventures Bermuda Limited (May 28, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Endo Ventures Bermuda Limited, Endo Finance LLC, Endo Finco Inc., and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Ventures Bermuda Limited (May 28, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.25% Senior Notes Due 2022 among Endo Ventures Bermuda Limited, Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 5.75% Senior Notes Due 2022 among Endo Netherlands B.V., Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Netherlands B.V. (5.375% Senior Notes due 2023)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 5.375% Senior Notes Due 2023 among Endo Netherlands B.V., Endo Limited, Issuers, Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Netherlands B.V. (July 10, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.00% Senior Notes Due 2019 among Endo Netherlands B.V., Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Netherlands B.V. (July 10, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.00% Senior Notes Due 2020 among Endo Netherlands B.V., Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Counterpart to Registration Rights Agreement by Endo Netherlands B.V. (7.25% Senior Notes due 2022)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
2014
Supplemental Indenture to 7.25% Senior Notes Due 2022 among Endo Netherlands B.V., Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Indenture for 5.375% Senior Notes Due 2023 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2014
Registration Rights Agreement among Endo Finance LLC, Endo Finco Inc., Guarantors, and Initial Purchasers (June 30, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
NY
2014
Agreement and Plan of Merger among DAVA Pharmaceuticals, Inc., Generics International (US), Inc., Generics Merger Sub Inc., Endo Pharmaceuticals Inc., and DAVA SR, LLC (June 24,...
Merger Agreements
Endo International plc
Pharmaceuticals
DE
2014
Endo International plc Insider Trading and Confidentiality Policy
Code of Ethics
Endo International plc
Pharmaceuticals
2014
First Amendment to Executive Employment Agreement between Endo Health Solutions Inc. and Susan Hall
Employment Agreements
Endo International plc
Pharmaceuticals
2014
Indenture for 7.00% Senior Notes Due 2019 by Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank as Trustee
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2014
Indenture Agreement for 7.00% Senior Notes Due 2020 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2014
Indenture for 7.25% Senior Notes Due 2022 among Endo Finance LLC, Endo Finco Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
DE
2014
Registration Rights Agreement among Endo Finance LLC, Endo Finco Inc., Initial Guarantors, and Dealer Managers
Registration Rights Agreements
Endo International plc
Pharmaceuticals
NY
2014
Registration Rights Agreement among Endo Finance LLC, Endo Finco Inc., Initial Guarantors, RBC Capital Markets, LLC, and Deutsche Bank Securities Inc. dated May 6, 2014
Registration Rights Agreements
Endo International plc
Pharmaceuticals
NY
2014
Registration Rights Agreement among Endo Finance LLC, Endo Finco Inc., Initial Guarantors, and Dealer Managers (May 6, 2014)
Registration Rights Agreements
Endo International plc
Pharmaceuticals
NY
2014
Stock Purchase Agreement between Grupo Farmacéutico Somar Shareholders and Endo Netherlands B.V. (April 29, 2014)
Purchase Agreements
Endo International plc
Pharmaceuticals
NY
2014
Fifth Supplemental Indenture to 7% Senior Notes Due 2019 – Endo Health Solutions Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Ninth Supplemental Indenture to 7.00% Senior Notes Due 2020 by Endo Health Solutions Inc. and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Fifth Supplemental Indenture to 7.25% Senior Notes Due 2022 – Endo Health Solutions Inc., Guarantors, and Wells Fargo Bank, N.A.
Indenture Agreements
Endo International plc
Pharmaceuticals
2014
Executive Employment Agreement between Endo Health Solutions Inc. and Susan Hall
Employment Agreements
Endo International plc
Pharmaceuticals
DE
2014